VAERS reports by lot

GSK Hepatitis A lot ZP72S: VAERS reports

31 VAERS reports list lot ZP72S as a GSK Hepatitis A vaccine, received between 2022-11-12 and 2024-12-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
31
Reports
0%
Marked serious
0
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction433%
Allergic / Anaphylactic325%
General / Systemic (non-local)217%
Neurological18%
Thrombotic / Hematological18%
Musculoskeletal18%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas8
Ohio5
New Jersey2
Michigan2
Wisconsin2
Oregon1
Iowa1
Hawaii1
Kansas1
Washington1
Missouri1
California1

Reports by month received

2022-113
2022-121
2023-011
2023-025
2023-032
2023-057
2023-082
2023-101
2024-011
2024-031
2024-041
2024-052
2024-061
2024-071
2024-101
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.